AAAAAA
Results:
1-17
|
Results: 17
Authors:
BAILEY NP
STUART NSA
BESSELL EM
CHILD JA
NORFOLK D
FLETCHER J
GRIEVE RJ
SIMMONS AV
BARNARD DL
JACK A
FARISH J
DUNN J
WOODROFFE CM
STACK C
CULLEN MH
Citation: Np. Bailey et al., 5-YEAR FOLLOW-UP OF A PROSPECTIVE RANDOMIZED MULTICENTER TRIAL OF WEEKLY CHEMOTHERAPY (CAPOMET) VERSUS CYCLICAL CHEMOTHERAPY (CHOP-MTX) IN THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMA, Annals of oncology, 9(6), 1998, pp. 633-638
Authors:
HORWICH A
CULLEN MH
STENNING SP
Citation: A. Horwich et al., PRIMARY CHEMOTHERAPY AFTER ORCHIECTOMY FOR STAGE-I AND STAGE-II NONSEMINOMA, Seminars in oncology, 25(2), 1998, pp. 154-159
Authors:
FOSSA SD
OLIVER RTD
STENNING SP
HORWICH A
WILKINSON P
READ G
MEAD GM
ROBERTS JT
RUSTIN G
CULLEN MH
KAYE SB
HARLAND SJ
COOK P
Citation: Sd. Fossa et al., PROGNOSTIC FACTORS FOR PATIENTS WITH ADVANCED SEMINOMA TREATED WITH PLATINUM-BASED CHEMOTHERAPY, European journal of cancer, 33(9), 1997, pp. 1380-1387
Authors:
HANCOCK BW
CULLEN MH
HUDSON GV
Citation: Bw. Hancock et al., ALTERNATING CHIVPP PAB1OE IS BETTER THAN PAB1OE ALONE AS INITIAL CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE (HD) - FIRST RESULTS OF A BRITISH NATIONAL LYMPHOMA INVESTIGATION (BNLI)/CENTRAL LYMPHOMA GROUP (CLG)STUDY/, European journal of cancer, 33, 1997, pp. 1186-1186
Authors:
DUCHESNE GM
STENNING SP
AASS N
MEAD GM
FOSSA SD
OLIVER RTD
HORWICH A
READ G
ROBERTS IT
RUSTIN G
CULLEN MH
KAYE SB
HARLAND SJ
COOK PA
Citation: Gm. Duchesne et al., RADIOTHERAPY AFTER CHEMOTHERAPY FOR METASTATIC SEMINOMA - A DIMINISHING ROLE, European journal of cancer, 33(6), 1997, pp. 829-835
Authors:
HORWICH A
SLEIJFER DT
FOSSA SD
KAYE SB
OLIVER RTD
CULLEN MH
MEAD GM
DEWIT R
DEMULDER PHM
DEARNALEY DP
COOK PA
SYLVESTER RJ
STENNING SP
Citation: A. Horwich et al., RANDOMIZED TRIAL OF BLEOMYCIN, ETOPOSIDE, AND CISPLATIN COMPARED WITHBLEOMYCIN, ETOPOSIDE, AND CARBOPLATIN IN GOOD-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL CANCER - A MULTIINSTITUTIONAL MEDICAL-RESEARCH-COUNCIL -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER TRIAL, Journal of clinical oncology, 15(5), 1997, pp. 1844-1852
Authors:
CULLEN MH
STENNING SP
PARKINSON MC
FOSSA SD
KAYE SB
HORWICH AH
HARLAND SJ
WILLIAMS MV
JAKES R
Citation: Mh. Cullen et al., SHORT-COURSE ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - A MEDICAL-RESEARCH-COUNCIL REPORT, Journal of clinical oncology, 14(4), 1996, pp. 1106-1113
Authors:
ALLEN SM
DUFFY JP
DARNTON SJ
MATTHEWS HR
CULLEN MH
Citation: Sm. Allen et al., PHASE-II STUDY OF MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN ADENOCARCINOMA OF THE ESOPHAGUS, Cancer chemotherapy and pharmacology, 37(5), 1996, pp. 496-498
Authors:
SMITH GM
CHILD JA
CULLEN MH
BAILEY NP
WOODRUFFE CM
FLETCHER J
EARL H
BARNARD D
Citation: Gm. Smith et al., A PHASE-I TRIAL TO ASSESS THE VALUE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (R-METHUG-CSF, FILGRASTIM) IN ACCELERATING THE DOSE-RATE OF CHEMOTHERAPY FOR INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA (NHL), Hematological oncology, 14(4), 1996, pp. 193-201
Authors:
CULLEN MH
BILLINGHAM LJ
COOK J
WOODROFFE CM
Citation: Mh. Cullen et al., MANAGEMENT PREFERENCES IN STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OFTHE TESTIS - AN INVESTIGATION AMONG PATIENTS, CONTROLS AND ONCOLOGISTS, British Journal of Cancer, 74(9), 1996, pp. 1487-1491
Authors:
CULLEN MH
Citation: Mh. Cullen, ADJUVANT AND NEOADJUVANT CHEMOTHERAPY IN NON-SMALL-CELL CARCINOMA, Annals of oncology, 6, 1995, pp. 43-48
Authors:
CULLEN MH
Citation: Mh. Cullen, TRIALS WITH MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN NONSMALL CELL LUNG-CANCER, Lung cancer, 12, 1995, pp. 95-106
Authors:
FERRY DR
CULLEN MH
Citation: Dr. Ferry et Mh. Cullen, CHEMOTHERAPY IN ADVANCED SMALL-CELL LUNG-CANCER, BMJ. British medical journal, 308(6933), 1994, pp. 920-920
Authors:
CULLEN MH
STUART NSA
WOODROFFE C
MURPHY A
FLETCHER J
BLACKLEDGE GRP
CHILD JA
GRIEVE RJ
JONES EL
CHETIYAWARDANA AD
EARL HM
GALVIN GP
ANDREWS VE
HARPER P
LEWIS ML
MOULD JJ
MURRAY JA
NORFOLK DR
OBEID D
OFFERMAN EL
SPOONER D
STABLEFORTH PG
TUCKER J
Citation: Mh. Cullen et al., CHLVPP PABLOE AND RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE/, Journal of clinical oncology, 12(4), 1994, pp. 779-787
Authors:
CULLEN MH
Citation: Mh. Cullen, TRIALS OF RADICAL RADIOTHERAPY VERSUS CHEMOTHERAPY PLUS RADICAL RADIOTHERAPY IN NONSMALL CELL LUNG-CANCER, Seminars in oncology, 21(3), 1994, pp. 34-41
Authors:
CULLEN MH
Citation: Mh. Cullen, SURVEILLANCE OR ETOPOSIDE-CONTAINING COMBINATION CHEMOTHERAPY FOR STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS (NSGCTT) - REPLY, British Journal of Cancer, 70(6), 1994, pp. 1277-1277
Authors:
CULLEN MH
Citation: Mh. Cullen, MITOMYCIN, IFOSFAMIDE, AND CISPLATIN IN NONSMALL CELL LUNG-CANCER, Oncology, 50, 1993, pp. 31-34
Risultati:
1-17
|